4
References:
- Human8 on behalf of GSK. Shingles Action Week 2026 Survey (Australia, Austria, Canada, China, France, Germany, India, Japan, Poland and UAE). Data on file. 2026.
- Harpaz R, et al. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(Rr-5):1–30.
- Johnson RW, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Therapeutic advances in vaccines. 2015;3(4):109–20.
- Mueller NH, et al. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurologic clinics. 2008;26(3):675–97.
- Bricout H, et al. Herpes zoster-associated mortality in Europe: a systematic review. BMC Public Health. 2015;15:466.
- Forbes, H.J., et al. Quantification o. f risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study. Neurology. 2016;87(1):94-102.
- Marra, F., et al. Risk Factors for Herpes Zoster Infection: A Meta-Analysis. Open forum infectious diseases. 2020;7
- Lin SY, et al. A comparison of Herpes Zoser incidence across the spectrum of chronic kidney disease, dialysis and transplanatation. Am J Nephrol. 2012:36(1):27–33.
- Huang C-T, et al. Association Between Diabetes Mellitus and the Risk of Herpes. J Clin Endocrinol Metab. 2022;107(2):586–597.
- Mortimer KJ, et al. Global herpes zoster burden in adults with asthma: a systematic review and meta-analysis. Eur Respir J. 2024;64(2):2400462.
This non-promotional microsite is for healthcare professionals which offers information on diseases and instructional materials. Use the content for educational purposes only.
NP-MY-HZU-WCNT-260001 02/26